PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $44,000 | -22.8% | 13,934 | -19.2% | 0.00% | -25.0% |
| Q1 2016 | $57,000 | -19.7% | 17,253 | -9.1% | 0.00% | -20.0% |
| Q4 2015 | $71,000 | -26.8% | 18,984 | -1.8% | 0.01% | -28.6% |
| Q3 2015 | $97,000 | -45.5% | 19,330 | -30.1% | 0.01% | -41.7% |
| Q2 2015 | $178,000 | -95.3% | 27,636 | -94.9% | 0.01% | -95.4% |
| Q1 2015 | $3,802,000 | -0.5% | 540,502 | +9.0% | 0.26% | -14.2% |
| Q4 2014 | $3,823,000 | +14.7% | 495,802 | +11.2% | 0.30% | +5.9% |
| Q3 2014 | $3,332,000 | -12.3% | 446,027 | +13.6% | 0.29% | -13.1% |
| Q2 2014 | $3,799,000 | +55.3% | 392,470 | +33.3% | 0.33% | +47.5% |
| Q1 2014 | $2,447,000 | +35.8% | 294,476 | +37.9% | 0.22% | +27.4% |
| Q4 2013 | $1,802,000 | +43.9% | 213,551 | +35.9% | 0.18% | +25.0% |
| Q3 2013 | $1,252,000 | +148.4% | 157,088 | +140.4% | 0.14% | +122.2% |
| Q2 2013 | $504,000 | – | 65,347 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |